Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Newly patented hydrazine derivatives from Roche inhibit TNF-alpha release

Feb. 4, 2000

Amarillo Biosciences' oral interferon alfa granted orphan drug status for Behcet's disease

Feb. 4, 2000

Hydroxamic acid-based MMP inhibitors in the DuPont pipeline

Feb. 1, 2000

Antisense oligonucleotides targeting TNFR1 expression designed at Isis

Feb. 1, 2000

RCT patents GH treatment regimen for rheumatoid arthritis

Jan. 31, 2000

Gene-based osteoarthritis collaboration initiated by Quark and Shionogi

Jan. 28, 2000

FDA approves new labeling for Hyalgan

Jan. 28, 2000

FDA allows NicOx to begin phase I trials of NO-NSAID

Jan. 27, 2000

Novel MCP-1 antagonists emerge from Warner-Lambert research

Jan. 27, 2000

Scios discusses plans for p38 kinase inhibitors

Jan. 26, 2000

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...